HDFC Mutual Fund Increases Stake in Global Health with ₹130 Crore Deal

HDFC Mutual Fund has further strengthened its position in the healthcare sector by acquiring an additional 10 lakh shares of Global Health, the parent company of the Medanta hospital chain. This strategic move comes on the heels of a similar large-scale acquisition last month, signaling growing institutional confidence in the company's growth trajectory.

Massive Block Deal via Open Market Transactions

In a significant block deal reported on the BSE, HDFC Mutual Fund purchased 10 lakh shares of Global Health at an average price of ₹1,300 per share. This transaction, valued at approximately ₹130 crore, represents a 0.37 per cent stake in the company. The shares were offloaded by Sunil Sachdeva, the co-founder of Medanta Hospitals.

This acquisition marks a pattern of increasing investment from the fund house. Just last month, HDFC Mutual Fund had already purchased 10 lakh shares from Sachdeva in a deal valued at over ₹122 crore. As of the end of the March quarter, Sachdeva held a substantial stake of 2.90 crore equity shares, accounting for 10.79 per cent of Global Health.

Robust Financial Performance Drives Investor Interest

The heightened interest from institutional investors like HDFC Mutual Fund aligns with the impressive financial milestones reported by Global Health. The company has demonstrated strong momentum in both revenue and profitability, making it an attractive prospect for long-term investors.

For the fourth quarter ended March 31, 2026, Global Health reported a massive 39.7 per cent surge in Profit After Tax (PAT), reaching ₹141.7 crore. This is a significant jump from the ₹101.4 crore profit posted in the same quarter of the previous fiscal year. Furthermore, the company's revenue from operations climbed to ₹1,159 crore, up from ₹931.3 crore in the corresponding period last year, showcasing its ability to scale operations effectively.

Market Reaction and Sector Outlook

Despite the large-scale transaction, the stock market showed a cautious reaction. Shares of Global Health saw a marginal dip of 0.41 per cent, closing at ₹1,311.35 apiece on the BSE. Such minor fluctuations are common during large block deals as the market absorbs the change in shareholding patterns.

The repeated accumulation of shares by one of India's largest mutual fund houses suggests that institutional players view Medanta's business model and the broader healthcare services sector as resilient and high-growth. As healthcare infrastructure continues to expand in India, companies with established brands like Medanta are well-positioned to capture rising demand.

Key Takeaways

  • Strategic Accumulation: HDFC Mutual Fund has increased its stake in Global Health by 0.37% through a ₹130 crore block deal, following a similar acquisition last month.
  • Strong Financial Growth: Global Health reported a nearly 40% increase in PAT to ₹141.7 crore and a significant rise in quarterly revenue to ₹1,159 crore.
  • Institutional Confidence: The repeated purchase of shares from co-founder Sunil Sachdeva highlights growing institutional trust in the Medanta brand's profitability and market position.